He has been succeeded on an interim basis by Jill Simmons, MD, professor of Pediatrics and founding director of the Program for Pediatric Metabolic Bone Disorders at Monroe Carell Jr. Children’s Hospital at Vanderbilt.

The program recognizes “the critical role of facilities providing care to patients with congenital heart disease who transition their care from pediatric cardiology to adult cardiology services.”

Markham succeeds Scott Baldwin, MD, who stepped down after leading the division for more than two decades.

Nearly a decade ago, neonatologists at Monroe Carell Jr. Children’s Hospital at Vanderbilt noticed a VKDB diagnosis uptick and called for a state and national tracking system.

For Rush, the most meaningful part of her journey has been the people — the children, their families, and the faculty, staff and trainees with whom she has worked over the years. 

These findings could lead to the development of cross-reactive and neutralizing antibody therapies for individuals who are severely ill from the flu.

This year, Monroe Carell is one of only 15 children’s hospitals nationwide to receive the Top Hospitals designation.